{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T22:53:31Z","timestamp":1777676011932,"version":"3.51.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T00:00:00Z","timestamp":1620086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T00:00:00Z","timestamp":1620086400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>A growing body of evidence suggests that opioid use may affect consumer\u2019s offspring by second-hand passive smoke exposure, as well as by transgenerational impacts mediated by genetic and epigenetic alterations of paternal gametes. In human studies, these effects are limited to investigating the neural, behavioral and cognitive characteristics of offspring. Only animal studies have investigated the metabolic parameters influenced by passive opium smoke exposure. Here, we conducted population-based analyses aimed to estimate the association of paternal opioid consumption, started before or after child birth, with BMI status and plasma lipid profile of young adult offspring. The present study includes 840 parents-offspring trios (offspring aged 15\u201335, parents aged 35\u201370) who participated in the prospective Rafsanjan Cohort Study (RCS)\u2014a city in the south-east of Iran\u2014as one of the district areas of the PERSIAN cohort (Prospective Epidemiological Research Studies in IrAN). All procedures for interviews, anthropometric measurements and physical examinations, biological sample collection and laboratory tests for blood biochemical parameters were conducted according to the PERSIAN cohort protocol, and in the well-established RCS setting. Crude and adjusted multiple logistic regression analysis were conducted to assess the relationship of paternal regular opioid use with offspring\u2019s BMI status, and plasma lipid factors. The prevalence of fathers who use opioids regularly among the studied trios was 42.8% (360\/840). Our regression analyses demonstrated that paternal opioid use started pre-fatherhood is associated with 76% higher adjusted odds ratio (OR) of overweight\/obesity in young offspring (adjusted OR 1.76 (95% CI 1.15\u20132.71)), adjusting for sex, age, parental BMIs, paternal smoking status and socioeconomic status index (WSI). This relationship persisted when fathers who used opioid by routes other than inhaling (oral) were excluded from logistic analysis (adjusted OR 1.73 (95% CI 1.12\u20132.68)). Interestingly, sex stratified analysis displayed a 201% increased odds ratio of overweight\/obesity in sons of fathers who use opioid regularly, started after child birth (Adjusted OR 3.01 (95% CI 1.68\u20135.39), while no significant association was found in daughters (adjusted OR 0.74 (95% CI 0.35\u20131.54)). Additionally, increasing exposure\u2013response relationships were observed between odds ratios of overweight\/obesity and the number of years of paternal opioid use after birth (p-trend\u2009=\u20090.0008). Paternal regular opioid use started pre-fatherhood was associated with 54% lowered risk of underweight [adjusted OR 0.46 (95% CI 0.24\u20130.86)]. Finally, paternal opioid consumption started either before or after child birth did not show a significant association with the high level of the three parameters of plasma lipid factors (triglyceride, cholesterol and HDL-cholesterol) in offspring. Our results suggest that the environmental impacts of paternal regular opioid use may be sufficient to make an effect on male offspring metabolism independent of genetic and epigenetic impact on gametes.<\/jats:p>","DOI":"10.1038\/s41598-021-88781-9","type":"journal-article","created":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T10:03:29Z","timestamp":1620122609000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Cohort-based analysis of paternal opioid use in relation to offspring\u2019s BMI and plasma lipid profile"],"prefix":"10.1038","volume":"11","author":[{"given":"Zahra","family":"Jalali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeed","family":"Bahrampour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parvin","family":"Khalili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morteza","family":"Khademalhosseini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Esmaeili Nadimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,4]]},"reference":[{"key":"88781_CR1","unstructured":"WHO. Noncommunicable diseases progress monitor (World Health Organization, 2017)."},{"key":"88781_CR2","unstructured":"Organization WH. WHO. Non communicable diseases country profiles: 2014 (World Health Organization, 2014), Accessed 10 Dec 2016."},{"key":"88781_CR3","unstructured":"Organization WH. Global status report on noncommunicable diseases 2014 (World Health Organization, 2014)."},{"key":"88781_CR4","unstructured":"Organization WH. Noncommunicable diseases progress monitor 2015 (2015)."},{"issue":"2","key":"88781_CR5","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s11906-018-0812-z","volume":"20","author":"MG Saklayen","year":"2018","unstructured":"Saklayen, M. G. The global epidemic of the metabolic syndrome. Curr. Hypertens. Rep. 20(2), 12 (2018).","journal-title":"Curr. Hypertens. Rep."},{"issue":"1770","key":"88781_CR6","doi-asserted-by":"publisher","first-page":"20180123","DOI":"10.1098\/rstb.2018.0123","volume":"374","author":"CH Fall","year":"2019","unstructured":"Fall, C. H. & Kumaran, K. Metabolic programming in early life in humans. Philos. Trans. R. Soc. B 374(1770), 20180123 (2019).","journal-title":"Philos. Trans. R. Soc. B"},{"key":"88781_CR7","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1146\/annurev-physiol-020911-153245","volume":"74","author":"P Rinaudo","year":"2012","unstructured":"Rinaudo, P. & Wang, E. Fetal programming and metabolic syndrome. Annu. Rev. Physiol. 74, 107\u2013130 (2012).","journal-title":"Annu. Rev. Physiol."},{"issue":"5","key":"88781_CR8","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1093\/ajcn\/59.5.955","volume":"59","author":"WH Dietz","year":"1994","unstructured":"Dietz, W. H. Critical periods in childhood for the development of obesity. Am. J. Clin. Nutr. 59(5), 955\u2013959 (1994).","journal-title":"Am. J. Clin. Nutr."},{"issue":"8","key":"88781_CR9","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s11892-015-0624-3","volume":"15","author":"A Vaiserman","year":"2015","unstructured":"Vaiserman, A. Early-life exposure to substance abuse and risk of type 2 diabetes in adulthood. Curr. Diab. Rep. 15(8), 48 (2015).","journal-title":"Curr. Diab. Rep."},{"issue":"1","key":"88781_CR10","first-page":"e15779","volume":"5","author":"R Derakhshan","year":"2014","unstructured":"Derakhshan, R., Roodpeyma, S., Balaee, P. & Bakhshi, H. A case-control study on perinatal outcomes of opium-addicted pregnant women and their offsprings in Rafsanjan. Iran. J. Compr. Pediatr. 5(1), e15779 (2014).","journal-title":"Iran. J. Compr. Pediatr."},{"issue":"3","key":"88781_CR11","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.clp.2013.05.015","volume":"40","author":"TJ Stanhope","year":"2013","unstructured":"Stanhope, T. J., Gill, L. A. & Rose, C. Chronic opioid use during pregnancy: Maternal and fetal implications. Clin. Perinatol. 40(3), 337\u2013350 (2013).","journal-title":"Clin. Perinatol."},{"issue":"4","key":"88781_CR12","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1097\/FTD.0b013e31822724f0","volume":"33","author":"A De Castro","year":"2011","unstructured":"De Castro, A. et al. Methadone, cocaine, opiates and metabolite disposition in umbilical cord and correlations to maternal methadone dose and neonatal outcomes. Ther. Drug Monit. 33(4), 443 (2011).","journal-title":"Ther. Drug Monit."},{"key":"88781_CR13","unstructured":"Moller M. Detection of Prenatal Opiate Exposures in Alternative Matrices 2010."},{"issue":"2","key":"88781_CR14","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.jep.2009.11.011","volume":"127","author":"H Najafipour","year":"2010","unstructured":"Najafipour, H., Joukar, S., Malekpour-Afshar, R., Mirzaeipour, F. & Nasri, H. R. Passive opium smoking does not have beneficial effect on plasma lipids and cardiovascular indices in hypercholesterolemic rabbits with ischemic and non-ischemic hearts. J. Ethnopharmacol. 127(2), 257\u2013263 (2010).","journal-title":"J. Ethnopharmacol."},{"issue":"3","key":"88781_CR15","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1111\/ejn.14060","volume":"50","author":"LR Goldberg","year":"2019","unstructured":"Goldberg, L. R. & Gould, T. J. Multigenerational and transgenerational effects of paternal exposure to drugs of abuse on behavioral and neural function. Eur. J. Neurosci. 50(3), 2453\u20132466 (2019).","journal-title":"Eur. J. Neurosci."},{"key":"88781_CR16","doi-asserted-by":"publisher","first-page":"702","DOI":"10.3389\/fphar.2018.00702","volume":"9","author":"F Gilardi","year":"2018","unstructured":"Gilardi, F., Augsburger, M. & Thomas, A. Will widespread synthetic opioid consumption induce epigenetic consequences in future generations?. Front. Pharmacol. 9, 702 (2018).","journal-title":"Front. Pharmacol."},{"issue":"4","key":"88781_CR17","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1093\/aje\/kwx314","volume":"187","author":"H Poustchi","year":"2018","unstructured":"Poustchi, H. et al. Prospective epidemiological research studies in Iran (the PERSIAN Cohort Study): Rationale, objectives, and design. Am. J. Epidemiol. 187(4), 647\u2013655 (2018).","journal-title":"Am. J. Epidemiol."},{"key":"88781_CR18","doi-asserted-by":"publisher","unstructured":"Hakimi, H. et al. The profile of Rafsanjan Cohort Study. Eur. J. Epidemiol. 36, 243\u2013252 (2021). https:\/\/doi.org\/10.1007\/s10654-020-00668-7","DOI":"10.1007\/s10654-020-00668-7"},{"key":"88781_CR19","volume-title":"Opium Poppy: Botany, Chemistry, and Pharmacology","author":"L Kapoor","year":"1995","unstructured":"Kapoor, L. Opium Poppy: Botany, Chemistry, and Pharmacology (CRC Press, 1995)."},{"key":"88781_CR20","doi-asserted-by":"publisher","unstructured":"Shakeri, R. et al. Opium use, cigarette smoking, and alcohol consumption in relation to pancreatic cancer. Medicine. 95(28), e3922 (2016). https:\/\/doi.org\/10.1097\/MD.0000000000003922.","DOI":"10.1097\/MD.0000000000003922"},{"issue":"12","key":"88781_CR21","doi-asserted-by":"publisher","first-page":"e0244826","DOI":"10.1371\/journal.pone.0244826","volume":"15","author":"C Eberle","year":"2020","unstructured":"Eberle, C., Kirchner, M. F., Herden, R. & Stichling, S. Paternal metabolic and cardiovascular programming of their offspring: A systematic scoping review. PLoS ONE 15(12), e0244826 (2020).","journal-title":"PLoS ONE"},{"issue":"5","key":"88781_CR22","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1161\/CIRCULATIONAHA.116.021511","volume":"134","author":"AM-F Yen","year":"2016","unstructured":"Yen, A.M.-F. et al. Longer duration and earlier age of onset of paternal betel chewing and smoking increase metabolic syndrome risk in human offspring, independently, in a community-based screening program in Taiwan. Circulation 134(5), 392\u2013404 (2016).","journal-title":"Circulation"},{"issue":"6","key":"88781_CR23","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1158\/1055-9965.1068.13.6","volume":"13","author":"CC Abnet","year":"2004","unstructured":"Abnet, C. C. et al. Reliability and validity of opiate use self-report in a population at high risk for esophageal cancer in Golestan, Iran. Cancer Epidemiol. Prev. Biomarkers. 13(6), 1068\u20131070 (2004).","journal-title":"Cancer Epidemiol. Prev. Biomarkers."},{"key":"88781_CR24","volume-title":"Applying Quantitative Bias Analysis to Epidemiologic Data","author":"TL Lash","year":"2011","unstructured":"Lash, T. L., Fox, M. P. & Fink, A. K. Applying Quantitative Bias Analysis to Epidemiologic Data (Springer Science & Business Media, 2011)."},{"issue":"11","key":"88781_CR25","first-page":"691","volume":"20","author":"S Eghtesad","year":"2017","unstructured":"Eghtesad, S. et al. The PERSIAN cohort: Providing the evidence needed for healthcare reform. Arch. Iran. Med. 20(11), 691\u2013695 (2017).","journal-title":"Arch. Iran. Med."},{"issue":"3","key":"88781_CR26","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s00404-018-4833-2","volume":"298","author":"JF Dos Santos","year":"2018","unstructured":"Dos Santos, J. F. et al. Maternal, fetal and neonatal consequences associated with the use of crack cocaine during the gestational period: A systematic review and meta-analysis. Arch. Gynecol. Obstet. 298(3), 487\u2013503 (2018).","journal-title":"Arch. Gynecol. Obstet."},{"issue":"12","key":"88781_CR27","doi-asserted-by":"publisher","first-page":"3429","DOI":"10.1007\/s00213-019-05307-y","volume":"236","author":"B Fant","year":"2019","unstructured":"Fant, B. et al. Preconception maternal cocaine self-administration increases the reinforcing efficacy of cocaine in male offspring. Psychopharmacology 236(12), 3429\u20133437 (2019).","journal-title":"Psychopharmacology"},{"issue":"2","key":"88781_CR28","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jnn.2015.09.002","volume":"22","author":"A Fraser","year":"2016","unstructured":"Fraser, A., Walker, K. & Green, J. Maternal cocaine abuse\u2014An evidence review. J. Neonatal Nurs. 22(2), 56\u201360 (2016).","journal-title":"J. Neonatal Nurs."},{"key":"88781_CR29","doi-asserted-by":"publisher","first-page":"108469","DOI":"10.1016\/j.neuropharm.2021.108469","volume":"186","author":"M Kumar","year":"2021","unstructured":"Kumar, M. et al. Sexually dimorphic neuroimmune response to chronic opioid treatment and withdrawal. Neuropharmacology 186, 108469 (2021).","journal-title":"Neuropharmacology"},{"key":"88781_CR30","doi-asserted-by":"publisher","unstructured":"Johnson, M. A. et al. Chronic stress differentially alters mRNA expression of opioid peptides and receptors in the dorsal hippocampus of female and male rats. J. Comp. Neurol. (2021).\nhttps:\/\/doi.org\/10.1002\/cne.25115.","DOI":"10.1002\/cne.25115"},{"key":"88781_CR31","doi-asserted-by":"publisher","first-page":"116926","DOI":"10.1016\/j.lfs.2019.116926","volume":"237","author":"SA Nasser","year":"2019","unstructured":"Nasser, S. A. & Afify, E. A. Sex differences in pain and opioid mediated antinociception: Modulatory role of gonadal hormones. Life Sci. 237, 116926 (2019).","journal-title":"Life Sci."},{"issue":"1","key":"88781_CR32","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41386-018-0127-4","volume":"44","author":"DL Averitt","year":"2019","unstructured":"Averitt, D. L., Eidson, L. N., Doyle, H. H. & Murphy, A. Z. Neuronal and glial factors contributing to sex differences in opioid modulation of pain. Neuropsychopharmacology 44(1), 155\u2013165 (2019).","journal-title":"Neuropsychopharmacology"},{"issue":"1\u20132","key":"88781_CR33","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1002\/jnr.23852","volume":"95","author":"HH Doyle","year":"2017","unstructured":"Doyle, H. H. & Murphy, A. Z. Sex differences in innate immunity and its impact on opioid pharmacology. J. Neurosci. Res. 95(1\u20132), 487\u2013499 (2017).","journal-title":"J. Neurosci. Res."},{"issue":"1","key":"88781_CR34","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/npp.2015.272","volume":"41","author":"EH Chartoff","year":"2016","unstructured":"Chartoff, E. H. & McHugh, R. K. Translational studies of sex differences in sensitivity to opioid addiction. Neuropsychopharmacology 41(1), 383 (2016).","journal-title":"Neuropsychopharmacology"},{"key":"88781_CR35","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.drugalcdep.2014.05.001","volume":"141","author":"J Gryczynski","year":"2014","unstructured":"Gryczynski, J., Schwartz, R. P., Mitchell, S. G., O\u2019Grady, K. E. & Ondersma, S. J. Hair drug testing results and self-reported drug use among primary care patients with moderate-risk illicit drug use. Drug Alcohol Depend. 141, 44\u201350 (2014).","journal-title":"Drug Alcohol Depend."},{"key":"88781_CR36","doi-asserted-by":"crossref","unstructured":"Harrison, L. D. & Hughes, A. The validity of self-reported drug use: Improving the accuracy of survey estimates (US Department of Health and Human Services, National Institutes of Health, 1997).","DOI":"10.1037\/e495622006-002"},{"issue":"2","key":"88781_CR37","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1080\/02791072.2003.10400010","volume":"35","author":"GS Yacoubian","year":"2003","unstructured":"Yacoubian, G. S., VanderWall, K. L., Johnson, R. J., Urbach, B. J. & Peters, R. J. Comparing the validity of self-reported recent drug use between adult and juvenile arrestees. J. Psychoactive Drugs 35(2), 279\u2013284 (2003).","journal-title":"J. Psychoactive Drugs"},{"issue":"5","key":"88781_CR38","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1037\/0033-2909.133.5.859","volume":"133","author":"R Tourangeau","year":"2007","unstructured":"Tourangeau, R. & Yan, T. Sensitive questions in surveys. Psychol. Bull. 133(5), 859 (2007).","journal-title":"Psychol. Bull."},{"issue":"9","key":"88781_CR39","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.3109\/10826089609063969","volume":"31","author":"S Magura","year":"1996","unstructured":"Magura, S. & Kang, S.-Y. Validity of self-reported drug use in high risk populations: A meta-analytical review. Subst. Use Misuse 31(9), 1131\u20131153 (1996).","journal-title":"Subst. Use Misuse"},{"issue":"8","key":"88781_CR40","doi-asserted-by":"publisher","first-page":"e0183017","DOI":"10.1371\/journal.pone.0183017","volume":"12","author":"H Rashidian","year":"2017","unstructured":"Rashidian, H. et al. Sensitivity of self-reported opioid use in case-control studies: Healthy individuals versus hospitalized patients. PLoS ONE 12(8), e0183017 (2017).","journal-title":"PLoS ONE"},{"issue":"10","key":"88781_CR41","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.annepidem.2008.06.001","volume":"18","author":"M Fendrich","year":"2008","unstructured":"Fendrich, M., Mackesy-Amiti, M. E. & Johnson, T. P. Validity of self-reported substance use in men who have sex with men: Comparisons with a general population sample. Ann. Epidemiol. 18(10), 752\u2013759 (2008).","journal-title":"Ann. Epidemiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-88781-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-88781-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-88781-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T07:43:54Z","timestamp":1670053434000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-88781-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,4]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["88781"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-88781-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,4]]},"assertion":[{"value":"17 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9462"}}